Comorbid substance use disorder and psychiatric illness

There is no commercial support for this activity. 

Target Audience

Psychiatrists, nurse practitioners, therapists 

Learning Objectives

Upon completion of this activity, learners should be better able to:​

  • Describe the distribution of co-occurring disorders (COD) mental health disorders in substance use disorders​.
  • Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders​.
  • Develop practical applications for integrating new and emerging science into practice​.
  • Implement differential therapeutics based on current evidence and in consideration of presented co-occurring disorders principles where specific evidence is lacking .​
  • Identify gaps in the field of CODs that future research can address​.
  • Review the different FDA-approved and non-FDA pharmacological and psychotherapeutic treatments for the management of SUD, and how to combine them with the treatment of COD management of alcohol withdrawal.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Attendance
Course opens: 
09/10/2024
Course expires: 
09/09/2025
Talkiatry Contractor cost:
$25.00
Talkiatry Employee cost:
$0.00
Cost:
$25.00
Peer reviewer(s)

Nidhi Sharoha, DO

has no relevant financial relationships to disclose at this time.
Planner(s)

Beth Banner, MPH, CHCP

has no relevant financial relationships to disclose at this time.

Jane Eisen, MD

has no relevant financial relationships to disclose at this time.

David Guggenheim, PsyD

has no relevant financial relationships to disclose at this time.

Ilisse Perlmutter, MD

has no relevant financial relationships to disclose at this time.

Anna Petti, MBA

has no relevant financial relationships to disclose at this time.

Nidhi Sharoha, DO

has no relevant financial relationships to disclose at this time.
Speaker(s)

Ricardo Restrepo, MD, MPH

has no relevant financial relationships to disclose at this time.

MCCD Psychiatry, the medical affiliate of Talkiatry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MCCD Psychiatry, the medical affiliate of Talkiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Attendance

Price

Talkiatry Contractor cost:
$25.00
Talkiatry Employee cost:
$0.00
Cost:
$25.00
Please login or register to take this course.